Objectives Given the rapidly evolving therapeutic landscape for type 2 diabetes (T2D) and chronic kidney disease (CKD), this study aimed to characterise the clinical profiles and real-world outcomes ...

Our study assessed the impact of using Control-IQ technology, an automated insulin delivery system, on achievement of a Healthcare Effectiveness Data and Information Set (HEDIS) quality measure ...

The Boost brand and the ADA are urging action for early detection of diabetes. Joshi added, "Supporting the American Diabetes Association reinforces our mission to empower individuals with the ...

A new national survey of over 580 school nurses and diabetes healthcare providers has revealed critical barriers to implementing the American Diabetes Association’s (ADA) Diabetes Medical Management ...

Dr. Andrew “Andy” Rhinehart will serve as the new chief scientific and medical officer for Sansum Diabetes Research Institute (SDRI), starting Sept. 2. “Dr. Rhinehart’s appointment comes at a ...

Santa Barbara, CA (August 19, 2025) — Andrew (Andy) Rhinehart, MD, FACP, FACE, CDCES will be serving as the new Chief Scientific and Medical Officer for SDRI, effective September 2, 2025. Dr.

Aim: We aimed to develop and internally validate a machine learning (ML)-based model for the prediction of the risk of type 2 diabetes mellitus (T2DM) in children with obesity. Methods: In total, 292 ...

Greater weight loss and more diabetes remission were seen among adult women with overweight, obesity and T2D. HealthDay News — For adult women with overweight or obesity and type 2 diabetes (T2D), ...

All three doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40. (HealthDay News) — The oral small-molecule glucagon-like peptide-1 ...

All 3 doses of orforglipron superior to placebo with respect to primary end point of change in HbA1c from baseline to week 40. HealthDay News — The oral small-molecule glucagon-like peptide-1 receptor ...

WEDNESDAY, June 25, 2025 (HealthDay News) -- For adult women with overweight or obesity and type 2 diabetes (T2D), replacing diet beverages (DBs) with water is associated with greater weight loss and ...